State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, National Clinical Research Center for Infectious Diseases, National Medical Center for Infectious Diseases, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
Cancer Control. 2022 Jan-Dec;29:10732748211051548. doi: 10.1177/10732748211051548.
The objective of our study was to investigate and compare the epidemiologic characteristics, prognostic factors, and survival between hepatocellular carcinoma (HCC) and intrahepatic cholangiocarcinoma (ICC) patients.
Age-adjusted incidence rates were evaluated from 1975 to 2016 using the Surveillance, Epidemiology, and End Results (SEER) database. Overall survival (OS) was investigated using the Kaplan-Meier method and log-rank test. Univariate and multivariate Cox regression analyses were performed to identify the independent prognostic factors for OS.
In the last 10 years, the incidence rate of ICC increased rapidly by 109% (annual percentage change (APC) = 8.24, 95% CI = 6.64 to 9.86; < .001), compared with a much more modest 12% increase in the incidence of HCC (APC = 1.59, 95% CI = .56 to 2.62; < .001). This trend persisted throughout the study across different age groups, sexes, and races. Males older than 70 years and of other races (non-African American and non-Caucasian) showed the highest incidence rates of HCC and ICC. Multivariate Cox regression analysis demonstrated that other race, married status, later year of diagnosis, more examined lymph nodes, and surgery were significant protective factors of OS in HCC patients. In contrast, the race and year of diagnosis were not independent prognostic factors, but radiation and chemotherapy were protective factors of OS in ICC patients. The median OS was 18 months and 12 months in HCC and ICC patients, respectively.
In the last 10 years, the incidence of HCC had a slow growth in the United States, whereas ICC showed a remarkable increase. The 5-year OS of the former has improved in recent years while that of the latter showed no significant improvement. Therefore, surgery could contribute to superior survival outcomes as compared to other treatments.
本研究旨在调查和比较肝细胞癌(HCC)和肝内胆管细胞癌(ICC)患者的流行病学特征、预后因素和生存情况。
利用监测、流行病学和最终结果(SEER)数据库评估 1975 年至 2016 年的年龄调整发病率。采用 Kaplan-Meier 法和对数秩检验评估总生存期(OS)。采用单因素和多因素 Cox 回归分析确定 OS 的独立预后因素。
在过去 10 年中,ICC 的发病率迅速增加了 109%(年变化百分比(APC)=8.24,95%CI=6.64 至 9.86;<0.001),而 HCC 的发病率仅增加了 12%(APC=1.59,95%CI=0.56 至 2.62;<0.001)。这一趋势在整个研究期间在不同的年龄组、性别和种族中都存在。70 岁以上的男性和其他种族(非非裔美国人和非白种人)的 HCC 和 ICC 发病率最高。多因素 Cox 回归分析表明,其他种族、已婚状态、较晚的诊断年份、更多检查的淋巴结和手术是 HCC 患者 OS 的显著保护因素。相比之下,种族和诊断年份不是 ICC 患者 OS 的独立预后因素,但放疗和化疗是 ICC 患者 OS 的保护因素。HCC 和 ICC 患者的中位 OS 分别为 18 个月和 12 个月。
在过去 10 年中,HCC 的发病率在美国呈缓慢增长趋势,而 ICC 则显著增加。近年来,前者的 5 年 OS 有所改善,而后者则没有显著改善。因此,与其他治疗方法相比,手术可能有助于获得更好的生存结果。